Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Animal Drug Compounding Market Outlook Highlights Rising Veterinary DemandThe right medication is not always available in the right strength, dosage form, or flavor for every animal. A dog may struggle with tablets, a [read full press release...]
- PharmaEssentia CorporationFrom Taiwan to the World: PharmaEssentia Expands Global Reach With New Drug Approvals, Overseas InvestmentsFrom Taiwan to the world: PharmaEssentia expands global reach with new drug approvals, overseas investments TAIPEI, Taiwan, October 16, 2026--PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clinical trials a
- Scinai Immunotherapeutics Ltd.Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant InducementScinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company operating a growing contract development and manufacturing organization ("CDMO") alongside an immunology-focused therapeutic development...
- Azitra, Inc.Azitra, Inc. Announces Reverse Stock SplitCommon Stock Will Begin Trading on a Split-Adjusted Basis on October 26, 2026 — Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced...
- Curis, Inc.Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional InvestorsCuris, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into...
- Royalty Pharma plcRoyalty Pharma declares fourth quarter 2026 dividendThe board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2026 of $0.235 per Class A ordinary share.
- Virion Therapeutics to Present Long-Term Follow-Up Data of VRON-0200 Treatment in Chronic Hepatitis B in a Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2026PHILADELPHIA, October 16, 2026--Virion Therapeutics, LLC , a clinical-stage biotechnology company, developing T cell-based immunotherapies that contain checkpoint modifiers , today announced that an abstract reporting long-term follow-up data of VRON-0200, its novel, first-in-class, immunotherapy for
- Palleon Pharmaceuticals Announces Oral Presentation of Interim Phase 2 trial data for HLX79/E-602 in Membranous Nephropathy at the 2026 American College of Rheumatology (ACR) Convergence– Presentation will provide interim Phase 2 clinical data on HLX79/E-602, a first-in-class human sialidase enzyme therapeutic, in patients with membranous nephropathy – WALTHAM, Mass., October 16, 2026--Palleon Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics for au
- Ironwood Pharmaceuticals, Inc.Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer– Tom McCourt to Retire from CEO Post After 17 Years at Ironwood and Four Decades of Distinguished Industry Leadership Bringing Transformational Medicines to Patients – BOSTON, October 16, 2026--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-
- 20 Years Old, with a 50/50 Chance of Survival: Does High-Risk Leukemia in Young Adults Represent a Failure in Research Priorities?ST. PETERSBURG, Fla., Oct. 16, 2026 (SEND2PRESS NEWSWIZRE) -- While modern pediatric leukemia treatment stands as one of oncology's greatest triumph stories, a quiet and urgent crisis persists for adolescent and young adult (AYA) patients diagnosed with high-risk acute blood cancers. St. Petersburg-based Jackson Copeland Foundation targets the massive survival disparity gap in AYA acute myeloid leukemia, raising funds for pioneering research with Oct. 30 Anchors & Irons Invitational charity golf tournament in Clearwater.
- Innovative Massage Therapy Expands Focus on Chronic Stress-Related Physical Tension in Albuquerque.As August workloads peak across New Mexico, Innovative Massage Therapy makes appointment-based therapeutic services available to clients throughout Albuquerque, Bernalillo County, Sandoval County, Rio Rancho, and Santa Fe. Albuquerque, NM, August 3, 2026 - The National Institute …
- Global Asthma Drugs Market Size, Share, Trends, and Forecast 2026-2035 | Biologics, Pediatric Expansion, and Asia-Pacific Demand Drive Growth to USD 41.18 Billion"Asthma Drugs Market by Mode of Administration; Medication; Application; Organization Type; Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035" has been added to ResearchAndMarkets.com's offering.